Fatty acid intake and breast cancer in the Spanish multicase-control study on cancer (MCC-Spain).


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 26 11 2018
accepted: 25 04 2019
pubmed: 10 5 2019
medline: 29 1 2021
entrez: 10 5 2019
Statut: ppublish

Résumé

To evaluate the association between dietary fat and fat subtype and breast cancer development. We conducted a case-control study with 1181 cases of incident breast cancer, diagnosed between 2007 and 2012, and 1682 population controls frequency matched (by age, sex, and region) from the Spanish multicenter case-control study MCC-Spain. We found a significant protective effect in premenopausal women of total fat intake [OR 0.51 95% CI (0.31-0.86) highest versus lowest tertile], but no effect was observed in menopausal women [OR 1.15 95% CI (0.83-1.60)]. Analyzing by type of fat, this protective effect persisted only for the monounsaturated fatty acids [OR 0.51 95% CI (0.32-0.82)]. In contrast, other fatty acids did not have a significant effect. In addition, a protection against risk of breast cancer was found when polyunsaturated fats were "substituted" by monounsaturated, maintaining the same total fat intake [OR 0.68 95% CI (0.47-0.99)]. Finally, analyzing by breast cancer subtype, we found no effect, except in premenopausal women where intake of moderate [OR 0.52 95% CI (0.33-0.82)] and high monounsaturated fatty acids [OR 0.47 95% CI (0.27-0.82)] maintains a protective effect against ER/PR + tumors. In contrast, in menopausal women, a high intake of monounsaturated fatty acids was associated with higher risk of HER2 + tumors [OR 2.00 95% CI (0.97-4.13)]. Our study shows a differential effect of monounsaturated fatty acids according to menopausal status and breast cancer subtype.

Identifiants

pubmed: 31069457
doi: 10.1007/s00394-019-01977-8
pii: 10.1007/s00394-019-01977-8
doi:

Substances chimiques

Dietary Fats 0
Fatty Acids 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1171-1179

Subventions

Organisme : Instituto de Salud Carlos III (ES)
ID : PI08/0533
Organisme : Instituto de Salud Carlos III (ES)
ID : PI08/1359
Organisme : Instituto de Salud Carlos III (ES)
ID : PI09/00773-Cantabria
Organisme : Instituto de Salud Carlos III (ES)
ID : PI09/01286-León
Organisme : Instituto de Salud Carlos III (ES)
ID : PI09/01903-Valencia
Organisme : Instituto de Salud Carlos III (ES)
ID : PI09/02078-Huelva
Organisme : Instituto de Salud Carlos III (ES)
ID : PI09/01662-Granada
Organisme : Instituto de Salud Carlos III (ES)
ID : PI11/01403
Organisme : Instituto de Salud Carlos III (ES)
ID : PI11/01889-FEDER
Organisme : Instituto de Salud Carlos III (ES)
ID : PI11/00226
Organisme : Instituto de Salud Carlos III (ES)
ID : PI11/01810
Organisme : Instituto de Salud Carlos III (ES)
ID : PI11/02213
Organisme : Instituto de Salud Carlos III (ES)
ID : PI12/00488
Organisme : Instituto de Salud Carlos III (ES)
ID : PI12/00265
Organisme : Instituto de Salud Carlos III (ES)
ID : PI12/01270
Organisme : Instituto de Salud Carlos III (ES)
ID : PI12/00715
Organisme : Instituto de Salud Carlos III (ES)
ID : PI12/00150
Organisme : Instituto de Salud Carlos III (ES)
ID : PI14/01219
Organisme : Instituto de Salud Carlos III (ES)
ID : PI14/0613
Organisme : Instituto de Salud Carlos III (ES)
ID : PI15/00069
Organisme : Instituto de Salud Carlos III (ES)
ID : PI15/00914
Organisme : Instituto de Salud Carlos III (ES)
ID : PI15/01032
Organisme : The Fundación Marqués de Valdecilla
ID : API 10/09

Références

Int J Epidemiol. 2006 Aug;35(4):1011-21
pubmed: 16672309
Int J Cancer. 2016 Apr 15;138(8):1894-904
pubmed: 26595162
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
pubmed: 22237781
Cancer Causes Control. 2016 Jun;27(6):759-73
pubmed: 27146840
Eur J Cancer. 2007 Jul;43(11):1731-40
pubmed: 17596928
Cancer Detect Prev. 2008;32(1):52-64
pubmed: 18400416
J Natl Cancer Inst. 2003 Jul 16;95(14):1079-85
pubmed: 12865454
Ann Intern Med. 2012 May 1;156(9):635-48
pubmed: 22547473
Cancer Res. 1997 Sep 15;57(18):3979-88
pubmed: 9307282
Asian Pac J Cancer Prev. 2011;12(9):2167-78
pubmed: 22296351
Nutr Cancer. 2008;60(4):492-504
pubmed: 18584483
Lancet. 2003 Jul 19;362(9379):212-4
pubmed: 12885485
Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):11-9
pubmed: 7894319
Cancer Prev Res (Phila). 2012 Feb;5(2):216-28
pubmed: 22166249
Anticancer Res. 2014 Dec;34(12):6861-75
pubmed: 25503112
Curr Pharm Des. 2011;17(8):813-30
pubmed: 21443482
Int J Cancer. 2006 Apr 1;118(7):1782-9
pubmed: 16231317
JAMA. 1999 Mar 10;281(10):914-20
pubmed: 10078488
J Clin Oncol. 2013 Nov 1;31(31):3997-4013
pubmed: 24101045
Am J Clin Nutr. 2011 Oct;94(4):1043-52
pubmed: 21865329
Arch Intern Med. 1998 Jan 12;158(1):41-5
pubmed: 9437377
J Natl Cancer Inst. 2004 Feb 4;96(3):218-28
pubmed: 14759989
Breast Cancer Res Treat. 2014 May;145(1):255-65
pubmed: 24715379
Int J Cancer. 2012 Nov 15;131(10):2465-9
pubmed: 22392404
Breast Cancer Res. 2013 Jan 29;15(1):R9
pubmed: 23360535
Eur J Clin Nutr. 1997 Oct;51(10):708-12
pubmed: 9347293
Ann Oncol. 2011 Aug;22(8):1736-47
pubmed: 21709140
Am J Epidemiol. 2006 Nov 15;164(10):990-7
pubmed: 16968865
J Natl Cancer Inst. 2014 Apr 09;106(5):
pubmed: 24718872
Nutr Cancer. 2002;44(1):23-34
pubmed: 12672638
Asian Pac J Cancer Prev. 2013;14(4):2207-12
pubmed: 23725113
Curr Pharm Biotechnol. 2006 Dec;7(6):495-502
pubmed: 17168666
Cancer Treat Res. 2014;159:289-309
pubmed: 24114487
Breast Cancer Res Treat. 1997 Feb;42(3):243-51
pubmed: 9065608
BMC Med. 2012 May 21;10:50
pubmed: 22613931
Br J Cancer. 2007 Dec 3;97(11):1570-6
pubmed: 17940510
J Natl Cancer Inst. 1995 Jan 18;87(2):110-6
pubmed: 7503842
Am J Hum Biol. 2011 Sep-Oct;23(5):601-8
pubmed: 21681848
Am J Epidemiol. 2009 Aug 15;170(4):519-27
pubmed: 19584129
Eur J Cancer Prev. 2004 Aug;13(4):319-26
pubmed: 15554560
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Natl Cancer Inst. 1984 Aug;73(2):457-61
pubmed: 6087007
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680
Eur J Cancer Prev. 2017 Sep;26(5):385-395
pubmed: 28746163
Am J Clin Nutr. 1997 Dec;66(6 Suppl):1548S-1556S
pubmed: 9394714

Auteurs

Trinidad Dierssen-Sotos (T)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain. dierssent@unican.es.
Facultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain. dierssent@unican.es.

Inés Gómez-Acebo (I)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Facultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.

Camilo Palazuelos (C)

Facultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.

Esther Gracia-Lavedan (E)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Beatriz Pérez-Gómez (B)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Cardiovascular and Metabolic Diseases Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Madalen Oribe (M)

Public Health Division of Gipuzkoa, Health Department, BioDonostia Research Institute, San Sebastian, Basque Country, Spain.

Vicente Martín (V)

Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain.

Marcela Guevara (M)

Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.

Paz Rodríguez-Cundín (P)

Servicio de Medicina Preventiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Guillermo Fernández-Tardón (G)

IUOPA, Universidad de Oviedo, Asturias, Spain.

Rafael Marcos-Gragera (R)

Research Group on Statistics, Econometrics and Health (GRECS), Universitat de Girona, Girona, Spain.
Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.

Ana Molina-Barceló (A)

Cancer and Public Health Area, FISABIO-Public Health, Valencia, Spain.

Marian Díaz-Santos (M)

Centro de Investigación en Recursos Naturales, Salud y Medio Ambiente (RENSMA), Universidad de Huelva, Huelva, Spain.

Gemma Castaño-Vinyals (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Nuria Aragonés (N)

Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Ana López-Gonzalez (A)

Servicio de Oncología, Complejo Asistencial Universitario de León, León, Spain.

Pilar Amiano (P)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, Health Department, BioDonostia Research Institute, San Sebastian, Basque Country, Spain.

Jesús Castilla (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Instituto de Salud Pública de Navarra, IdiSNA, Pamplona, Spain.

Jessica Alonso-Molero (J)

Facultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.

Manolis Kogevinas (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
ISGlobal, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

Marina Pollán (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Cancer Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain.

Javier Llorca (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBER de Epidemiología Y Salud Pública-CIBERESP), Madrid, Spain.
Facultad de Medicina, Universidad de Cantabria-IDIVAL, Avda. Herrera Oria s/n, 39011, Santander, Spain.
ISGlobal, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH